Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - SPECTRASCIENCE INC | v234970_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 13, 2011
SPECTRASCIENCE, INC.
(Exact name of registrant as specified in its charter)
|
Minnesota
(State of other jurisdiction of incorporation)
|
000-13092
(Commission File Number)
|
41-1448837
(I.R.S. Employer Identification No.)
|
11568-11 Sorrento Valley Road, San Diego, CA 92121
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (858) 847-0200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registration under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
||
On September 13, 2011, executive officers of SpectraScience, Inc. (the “Company”) gave a presentation to certain investment advisors and other persons regarding the Company’s product portfolio and market opportunities. The Company’s presentation slides are attached as Exhibit 99.1 to this current report on Form 8-K.
This Item 7.01 Current Report on Form 8-K, including Exhibit 99.1, contains statements of a forward-looking nature which represent the Company’s beliefs and assumptions concerning future events. When used in this document and in documents incorporated herein by reference, the words “believe,” “expect,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve risks, uncertainties and assumptions, and are based on information currently available to the Company. Actual results may differ materially from those expressed in the forward-looking statements due to many factors, including, without limitation, those disclosed under “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010 and quarterly reports on Form 10-Q. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances that may arise after the date of this report.
(d) Exhibits
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Company Presentation Dated September 13, 2011
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: September 15, 2011
|
SPECTRASCIENCE, INC.
By: /s/ Jim Dorst
|
|
Jim Dorst
Its: Chief Financial Officer and Chief Operating Officer
|
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Company Presentation Dated September 13, 2011
|